WAT vs ZBH
Waters Corporation vs Zimmer Biomet — AI-powered side-by-side comparison
WAT
Waters Corporation
70
Buy
VS
| Metric | WAT | ZBH |
|---|
| AI Score |
70
|
70
|
| Price |
$406.91
|
$96.61
|
| P/E Ratio |
101.21×
|
23.38×
|
| ROE |
25.1%
|
5.6%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
50.8%
|
69.9%
|
| Debt / Equity |
0.33×
|
0.59×
|
| Dividend Yield |
0.0%
|
1.0%
|
| RSI (14) |
75.0
|
58.9
|
| Beta |
1.202
|
0.468
|
| Expected Upside |
+0.2%
|
+1.2%
|
AI Committee View
Current Innellis committee reasoning for WAT versus ZBH.
The committee scores are tied.
WAT and ZBH both score 70/100.
WAT Committee View
75% agreement
4 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is rsi at 75 is in overbought territory. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- RSI at 75 is in overbought territory — Technical
- Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
ZBH Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Risk/reward is unfavorable: 11.2% downside vs 1.2% upside.